|
|
| |
L-ArginineM2®
Safe and Effective L-Arginine |
| • |
Formulated
& Patented by L-Arginine Researchers |
| • |
The
only L-Arginine PROVEN SAFE in humans long-term |
| • |
L-Arginine
M2® is a Patented drink that provides all the benefits
of the amino acid L-Arginine |
|
| |
L-ArginineM2®
is a Patented
Amino Acid Formula
Backed by a Registered Federal Government
Patent
and (3) Patents-Pending
Validated by 25 Years of L-Arginine Research |
|
L-ArginineM2®
A Safe Pathway for L-Arginine |
L-ArginineM2
represents the First Generation of safe and effective L-arginine,
as L-ArginineM2 is the first L-arginine product proven to
be safe in humans long-term.
L-ArginineM2 is also the only L-arginine product to be used
safely in humans over a 25-year period (since 1983).
L-ArginineM2
was developed in 1983, and is the first arginine formula ever
attached to a Blind Amino Acid ® Rider, thus rendering
it a safe amino acid. |
| When
co-administered with a Blind Amino Acid Rider, L-Arginine
may be utilized orally in humans safely long-term.
Without
a Blind Amino Acid Rider, oral ingestion of L-Arginine has
been shown in clinical trials (Journal of the American Medical
Association/Johns Hopkins University) to result in mortality.
|
|
 |
|
What
is a Blind Amino Acid ? |
All
forms of L-arginine are “Blind Amino Acids”
which requires that L-arginine be bound to a Blind Amino
Acid ® Rider, and biochemically directed to access
safe arginine Isoform Pathways.
Dr.
Ann de Wees Allen, the inventor and Patent-holder of L-ArginineM2,
was the first scientist to discover a safe and effective
Isoform Pathway for L-arginine via inclusion of a “Blind
Amino Acid ® Rider.”
For
this research, spanning over 25 years, Dr. Allen received
the first glycemic patent ever awarded worldwide, (named
Breakthrough Product of the Year by Success magazine)
and the first patent on L-arginine attached to a Blind
Amino Acid ® Rider.
This
research resulted in the only long-term proven safe and
efficacious form of L-arginine, known as L-ArginineM2.
|
L-Arginine
products that do not contain a Blind Amino Acid ®
Rider have not been proven to be safe in humans long
term.
Dr. Allen's L-Arginine has been sold broadly to the
public since 1983.
Dr. Allen discovered
in 1983 that L-Arginine was not safe in humans long-term
without a Blind Amino Acid ®
Rider.
Only Dr Allen's L-Arginine contains a Blind Amino
Acid ® Rider, and no other product can
claim to contain a Blind Amino
Acid ® Rider. It is a Federal
Offense for a product other than Dr. Allen's patented
L-Arginine to claim that it contains a Blind
Amino Acid ® Rider. |
|
|
|
|
L-ArginineM2®
was named in
honor of Albert Einstein |
|
| |
|
“Science
without religion is lame and,
conversely, religion without science is blind.
Both are important and should work hand-in-hand”
Albert Einstein
Theory of Relativity E=MC²
Nobel Prize in Physics
L-ArginineM²
was named in honor of
Albert Einstein
|
|
| |
M²
relates to Einstein’s theory of relativity e=mc²
|
Albert Einstein: Nobel Prize winning physicist, whose research
and discoveries in Quantum Theory include the Theory of Relativity
(mass-energy equivalence, e=mc²), and Einstein’s
research on Avogadro’s number (6.02 x1023).
|
|
 |
Dr.
Ann de Wees Allen
Dr. Ann de Wees Allen is a dyslexic-savant, as was Einstein.
A dyslexic’s nonlinear images allows them to think
much more quickly and multi-dimensionally. Einstein
was able to develop his theory of relativity due to
his dyslexic properties of creativity and ability to
make intuitive leaps. As a tribute to Einstein, in 1983
Dr. Allen named her L-Arginine formula L-ArginineM2.
|
|
|
|
|
 |
|
L-ArginineM2
contains 5,000 mg (5 grams) of elemental pharmaceutical grade
l-arginine in the most easily metabolized form.
L-ArginineM2
does not contain the inferior forms of l-arginine, such as
HCL. The unique, proprietary flavor system in L-ArginineM2
negates the very unpleasant taste of l-arginine, thus providing
the first "great-tasting" l-arginine product.
The exclusive patented L-ArginineM2
formula was developed by leading l-arginine researcher Dr.
Ann de Wees Allen. Dr. Allen received the first glycemic patent
ever awarded for her development of the low glycemic delivery
system in L-ArginineM2.
The methodology developed exclusively for L-ArginineM2
is proprietary, and involves a complex 32-step process to
extract non-competing properties from a variety of organically
grown fruits.
L-ArginineM2
is used and promoted by famous world-class athletes who use
it to bolster their nutritional intake and enhance their athletic
performance. Some have even won Gold Medals in world-class
competition.
L-ArginineM2
is legal for use in the Olympic Games, IFBB world bodybuilding
competitions, WPF powerlifting events, fitness pageants and
NFL events.
L-ArginineM2
is an L-arginine amino acid formula backed by over 20 years
of research and a registered Federal government Patent.
L-ArginineM2
is the only L-arginine formula that can claim:
| • |
2 decades of L-arginine research |
| • |
Safe use by over 250,000 human subjects |
| • |
Safe
use in humans over a longer period than any other L-arginine
product (since 1983) |
| • |
Over
100,000 pages of documentation |
| • |
Only L-arginine that contains a Rider for Blind Amino
Acids |
| • |
Only
Certified Low Glycemic L-arginine product |
L-ArginineM2
is the result of the entire body of work conducted by Dr.
Ann de Wees Allen, with two-decades of documented
safe L-arginine use in humans.
|
|
|
|
What
is the functionality
of
L-ArginineM2®
? |
L-ArginineM2®
is the Key Code
to turning on your body's
"Metabolic Switch" |
|
L-ArginineM2
is directed at harnessing the benefits of the amino acid
L-arginine.
L-arginine
is considered the most potent Nutraceutical ever discovered,
due to its powerful health properties, and is referred to
by scientists as the “Miracle Molecule.”
The
remarkable properties of L-arginine were validated by the
1998 Nobel Prize in Medicine, and since then have created
a frenzy of interest in the Pharmaceutical and Nutraceutical
fields.
Columbia
University refers to L-arginine as the “Magic Bullet”
in human health. Over 10,000 L-arginine citations have been
compiled by Columbia University researchers in their quest
to document the benefits of this simple amino acid. It is
now taught to medical students at the Columbia University
College of Physicians and Surgeons.
The
Nobel Prize landmark discovery of the functions of Nitric
Oxide (NO) highlighted the fact that without NO, human life
would be impossible. Even more revolutionary was the irrefutable
evidence that L-arginine is the sole NO molecule in the
human body.
Twenty
years ago, the idea that a simple and humble amino acid
could change the face of medicine would have been dismissed.
Now, physicians, researchers, and scientists are embracing
the effectiveness of L-arginine and its use has become mainstream.
|
|
|
| |
L-ArginineM2® has been approved for
use by
OLYMPIC AND PROFESSIONAL ATHLETES
L-ArginineM2®
passes all analytical protocols
for DRUG-FREE Athletes
Click
Here for More Information
|
These
statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose,
treat, cure or prevent any disease.
|
L-ArginineM2®
is backed by a registered federal government Patent, Patents-Pending,
and two decades of L-Arginine Research |
Illegal
copying of this material is a Federal Offense and violators
will be prosecuted |
|
|
